Guilherme Curty Lechuga currently is a CNPq postdoctoral fellow at the Center for Technological Development in Health (CDTS) at the Oswaldo Cruz Foundation (FIOCRUZ). Dr. Lechuga received a BS. degree in Biomedicine from the Fluminense Federal University (UFF) as well as an MS. and PhD. in Science and Biotechnology from UFF. He has experience in cell biology and biochemistry techniques for preclinical drug development studies. One line of his research is focused on the study of metabolic targets against Trypanosoma cruzi, the causative agent of Chagas disease. Another concerns the application of data mining to direct rational drug design and the repositioning of existing drugs for the treatment of infectious diseases affecting neglected, under-served populations. In addition, he is currently working on the study of heme and iron dysmetabolism in COVID-19 patients.